Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 26, No 18 (June 20), 2008: pp. 2943-2951
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.13.8933

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Altgassen, C.
Right arrow Articles by Schneider, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altgassen, C.
Right arrow Articles by Schneider, A.
Related Articles
Right arrowRelated Editorial

Multicenter Validation Study of the Sentinel Lymph Node Concept in Cervical Cancer: AGO Study Group

Christopher Altgassen, Hermann Hertel, Antje Brandstädt, Christhardt Köhler, Matthias Dürst, Achim Schneider

From the Department of Obstetrics and Gynecology, University of Schleswig-Holstein, Luebeck; Department of Obstetrics and Gynecology, Medical School Hannover, Hannover; Information Sciences and Documentation, Institute of Medical Statistics, and Department of Obstetrics and Gynecology, Friedrich-Schiller-University, Jena; and Department of Gynecology and Gynecologic Oncology, Universitätsmedizin Berlin, Charité, Berlin, Germany

Corresponding author: Achim Schneider, MD, MPH, Universitätsmedizin Berlin, Charité, Department of Gynecology and Gynecologic Oncology, Hindenburgdamm 30, D-12203 Berlin, Germany; e-mail: achim.schneider{at}charite.de

Purpose: Single-institution case series have demonstrated the feasibility of the sentinel concept in cervical cancer. However, the diagnostic accuracy remains to be validated. We evaluated detection rate and diagnostic accuracy to predict the histopathologic pelvic nodal status in patients with cervical cancer of all stages.

Patients and Methods: In a hypothesis-based, prospective, multicenter cohort study, patients underwent lymph node detection after labeling with technetium, patent blue, or both. After systematic pelvic and, if indicated, para-aortic node dissection, all lymph nodes were histopathologically examined. Detection rate, sensitivity, and negative predictive value (NPV) were calculated.

Results: According to the protocol, 590 patients were eligible. Detection rate of pelvic sentinel nodes was 88.6% (95% CI, 85.8% to 91.1%) and was significantly higher for the combination of technetium and patent blue (93.5%; 95% CI, 90.3% to 96.0%). Of 106 patients with pelvic lymph node metastases, 82 had pelvic sentinel node metastases. The overall sensitivity was 77.4% (95% CI, 68.2% to 85.0%), which was lower than 90%, the predefined noninferiority margin (P < .001). Sensitivity in women with tumors ≤ 20 mm (90.9%), with bilateral detection (87.2%), or with both substances applied (80.3%) was higher compared with the total population. The overall NPV was 94.3% (95% CI, 91.6% to 96.4%) and was higher in patients with tumors ≤ 20 mm (99.1%; 95% CI, 96.6% to 100%) compared with patients with tumors more than 20 mm (88.5%; 95% CI, 82.9% to 92.8%; P < .001).

Conclusion: In our cohort (all stages), sensitivity of the sentinel concept was low. However, patients with tumor diameter ≤ 20 mm may profit from this concept.

Supported in part by the Deutsche Krebshilfe (German Cancer Aid), Bonn, Germany.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Related Editorial

  • Quality Control in Sentinel Lymph Node Biopsy in Cervical Cancer
    Lilian T. Gien and Allan Covens
    JCO 2008 26: 2930-2931 [Full Text]


This article has been cited by other articles:


Home page
Hum ReprodHome page
S. Mechsner, M. Weichbrodt, W.F.J. Riedlinger, J. Bartley, A.M. Kaufmann, A. Schneider, and C. Kohler
Estrogen and progestogen receptor positive endometriotic lesions and disseminated cells in pelvic sentinel lymph nodes of patients with deep infiltrating rectovaginal endometriosis: a pilot study
Hum. Reprod., July 16, 2008; (2008) den259v1.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. T. Gien and A. Covens
Quality Control in Sentinel Lymph Node Biopsy in Cervical Cancer
J. Clin. Oncol., June 20, 2008; 26(18): 2930 - 2931.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online